94 related articles for article (PubMed ID: 31711559)
1. MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC.
Liao Z; Zheng Q; Wei T; Zhang Y; Ma J; Zhao Z; Sun H; Nan K
Oncol Res; 2020 Mar; 28(2):147-159. PubMed ID: 31711559
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
[TBL] [Abstract][Full Text] [Related]
3. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
Liu C; Liu Z; Li X; Tang X; He J; Lu S
Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
[TBL] [Abstract][Full Text] [Related]
5. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
6. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.
Yang N; Chen J; Zhang H; Wang X; Yao H; Peng Y; Zhang W
Cell Death Dis; 2017 Aug; 8(8):e2975. PubMed ID: 28796257
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.
Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J
Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-10a promotes granulosa cells tumor development via PTEN-AKT/Wnt regulatory axis.
Tu J; Cheung HH; Lu G; Chen Z; Chan WY
Cell Death Dis; 2018 Oct; 9(11):1076. PubMed ID: 30348959
[TBL] [Abstract][Full Text] [Related]
10. miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.
Zhang H; Wang R; Deng Q
Comput Math Methods Med; 2022; 2022():3110330. PubMed ID: 36003920
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer.
Zhao L; Xue M; Zhang L; Guo B; Qin Y; Jiang Q; Sun R; Yang J; Wang L; Liu L; Wang X; Huang C; Tong D
Cancer Gene Ther; 2020 Jun; 27(6):461-472. PubMed ID: 31303644
[TBL] [Abstract][Full Text] [Related]
12. βKlotho is identified as a target for theranostics in non-small cell lung cancer.
Li F; Li X; Li Z; Ji W; Lu S; Xia W
Theranostics; 2019; 9(25):7474-7489. PubMed ID: 31695781
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Membrane Protein 2 Suppresses Non-Small Cell Lung Cancer Cell Growth by Inhibition of MAPK Pathway.
Ma Y; Schröder DC; Nenkov M; Rizwan MN; Abubrig M; Sonnemann J; Murrieta-Coxca JM; Morales-Prieto DM; Westermann M; Gaßler N; Chen Y
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799364
[TBL] [Abstract][Full Text] [Related]
14. USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer.
Zhu M; Zhang H; Lu F; Wang Z; Wu Y; Chen H; Fan X; Yin Z; Liang F
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34533198
[TBL] [Abstract][Full Text] [Related]
15. The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer.
Wang Y; Yang W; Pu Q; Yang Y; Ye S; Ma Q; Ren J; Cao Z; Zhong G; Zhang X; Liu L; Zhu W
J Biomed Sci; 2015 Jul; 22(1):52. PubMed ID: 26156586
[TBL] [Abstract][Full Text] [Related]
16. Promoter A1312C mutation leads to microRNA-7 downregulation in human non-small cell lung cancer.
Chen S; Wang H; Guo M; Zhao X; Yang J; Chen L; Zhao J; Chen C; Zhou Y; Xu L
Cell Signal; 2024 May; 117():111095. PubMed ID: 38346527
[TBL] [Abstract][Full Text] [Related]
17. Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancer.
Weber R; Meister M; Muley T; Thomas M; Sültmann H; Warth A; Winter H; Herth FJF; Schneider MA
Int J Oncol; 2019 Feb; 54(2):515-526. PubMed ID: 30535430
[TBL] [Abstract][Full Text] [Related]
18. miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN.
Gao Z; Ye X; Bordeaux A; Hettich S; Lin S; Han F; Jia Y
Eur J Histochem; 2021 Feb; 65(1):. PubMed ID: 33634678
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression By Targeting PDK1/PI3K/AKT Pathway.
Wei Y; Liao Y; Deng Y; Zu Y; Zhao B; Li F
Onco Targets Ther; 2019; 12():9005-9016. PubMed ID: 31802909
[TBL] [Abstract][Full Text] [Related]
20. MiR-421 promotes lipid metabolism by targeting PTEN via activating PI3K/AKT/mTOR pathway in non-small cell lung cancer.
Xu YJ; Wei RS; Li XH; Li Q; Yu JR; Zhuang XF
Epigenomics; 2022 Jan; ():. PubMed ID: 35045733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
